Mycoremediation of diclofenac using Mucor hiemalis

References

• Ahlgren, M. 2015. “Remediation of Diclofenac in a Non-Sterile Bioreactor Using the White Rot Fungus Trametes Versicolor.” Master thesis, Uppsala University.
   Google Scholar
• Andreozzi, R., M. Raffaele, and P. Nicklas. 2003. “Pharmaceuticals in STP Effluents and Their Solar Photodegradation in Aquatic Environments.” Chemosphere 50 (10): 1319–1330.
   PubMed Web of Science ®Google Scholar
• Balsano, E., M. Esterhuizen-Londt, E. Hoque, and S. Pflugmacher. 2015. “Toxin Resistance in Aquatic Fungi Poses Environmentally Friendly Remediation Possibilities: A Study on the Growth Responses and Biosorption Potential of Mucor hiemalis EH5 against Cyanobacterial Toxins.” International Journal of Water and Wastewater Treatment 1 (1): 1–9.
   Google Scholar
• Balsano, E., M. Esterhuizen-Londt, E. Hoque, and S. Pflugmacher. 2016. “Fungal Pellets as Potential Tools to Control Water Pollution: Strategic Approach for the Pelletization and Subsequent Microcystin-LR Uptake by Mucor hiemalis.” Journal of Applied Biology and Biochemistry 4 (4): 31–41.
   Google Scholar
• Bartha, B. 2012. “Uptake and Metabolism of Human Pharmaceuticals in Plants: Identification of Metabolites and Specification of the Defense Enzyme Systems under Pharmaceutical Exposure.” PhD thesis. Technische Universität München.
   Google Scholar
• Bartha, B., C. Huber, and P. Schröder. 2014. “Uptake and Metabolism of Diclofenac in Typha latifolia–How Plants Cope with Human Pharmaceutical Pollution.” Plant Science 227: 12–20.
   PubMed Web of Science ®Google Scholar
• Buser, H. R., T. Poiger, and M. D. Müller. 1998. “Occurrence and Fate of the Pharmaceutical Drug Diclofenac in Surface Waters: Rapid Photodegradation in a Lake.” Environmental Science and Technology 32 (22): 3449–3456.
   Web of Science ®Google Scholar
• Carballa, M., F. Omil, and J. M. Lema. 2005. “Removal of Cosmetic Ingredients and Pharmaceuticals in Sewage Primary Treatment.” Water Research 39 (19): 4790–6.
   PubMed Web of Science ®Google Scholar
• Clara, M., B. Strenn, O. Gans, E. Martínez, N. Kreuzinger, and H. Kroiss. 2005. “Removal of Selected Pharmaceuticals, Fragrances and Endocrine Disrupting Compounds in a Membrane Bioreactor and Conventional Wastewater Treatment Plants.” Water Research 39: 4797–4807.
   PubMed Web of Science ®Google Scholar
• Cruz-Morató, C., D. Lucas, M. Llorca, S. Rodriguez-Mozaz, M. Gorga, M. Petrovic, D. Barceló, T. Vicent, M. Sarrà, and E. Marco-Urrea. 2014. “Hospital Wastewater Treatment by Fungal Bioreactor: Removal Efficiency for Pharmaceuticals and Endocrine Disruptor Compounds.” Science of the Total Environment 493: 365–376.
   PubMed Web of Science ®Google Scholar
• Daughton, C. G., and T. A. Ternes. 1999. “Pharmaceuticals and Personal Care Products in the Environment: Agents of Subtle Change?” Environmental Health Perspectives 107 (6): 907–938.
   PubMed Web of Science ®Google Scholar
• De Liguoro, M., V. Cibin, F. Capolongo, B. Halling-Sørensen, and C. Montesissa. 2003. “Use of Oxytetracycline and Tylosin in Intensive Calf Farming: Evaluation of Transfer to Manure and Soil.” Chemosphere 52 (1): 203–212.
   PubMed Web of Science ®Google Scholar
• Dietrich, D. R., and A. Prietz. 1999. “Fish Embryotoxicity and Teratogenicity of Pharmaceuticals, Detergents and Pesticides Regularly Detected in Sewage Treatment Plant Effluents and Surface Waters.” Toxicologist 48 (1): 151.
   Google Scholar
• Dietrich, D. R., S. Webb, and T. Petry. 2005. Hot Spot Pollutants: Pharmaceuticals in the Environment. Bruxelles: Academic Press.
   Google Scholar
• Esterhuizen-Londt, M., K. Schwartz, and S. Pflugmacher. 2016a. “Using Aquatic Fungi for Pharmaceutical Bioremediation: Uptake of Acetaminophen by Mucor hiemalis Does Not Result in an Enzymatic Oxidative Stress Response.” Fungal Biology 120 (10): 1249–1257.
   PubMed Web of Science ®Google Scholar
• Esterhuizen-Londt, M., K. Schwartz, E. Balsano, S. Kühn, and S. Pflugmacher. 2016b. “LC–MS/MS Method Development for Quantitative Analysis of Acetaminophen Uptake by the Aquatic Fungus Mucor hiemalis.” Ecotoxicology and Environmental Safety 128: 230–235.
   PubMed Web of Science ®Google Scholar
• EU Directive 2013/39/EU. 2013. European Parliament and of the Council Amending Directives 2000/60/EC and 2008/105/EC as Regards Priority Substances in the Field of Water Policy. Off. J. Eur. Commun. 226: 1–17. Accessed 21 July 2016. http://eur-lex.europa.eu/legal-content/en/ALL/?uri=CELEX%3A32013L0039.
   Google Scholar
• Green, R. E., I. A. N. Newton, S. Shultz, A. A. Cunningham, M. Gilbert, D. J. Pain, and V. Prakash. 2004. “Diclofenac Poisoning as a Cause of Vulture Population Declines Across the Indian Subcontinent.” Journal of Applied Ecology 41 (5): 793–800.
   Web of Science ®Google Scholar
• Grundwasser, K. I. B. O. U., T. Heberer, K. Schmidt-Bäumler, and H. J. Stan. 1998. “Occurrence and Distribution of Organic Contaminants in the Aquatic System in Berlin. Part I: Drug Residues and Other Polar Contaminants in Berlin Surface and Groundwater.” Acta Hydrochimica et Hydrobiologica 26 (5): 272–278.
   Google Scholar
• Hata, T., S. Kawai, H. Okamura, and T. Nishida. 2010. “Removal of Diclofenac and Mefenamic Acid by the White Rot Fungus Phanerochaete sordida YK-624 and Identification of their Metabolites After Fungal Transformation.” Biodegradation 21: 681–9.
   PubMed Web of Science ®Google Scholar
• Hong, H. N., H. N. Kim, K. S. Park, S. K. Lee, and M. B. Gu. 2007. “Analysis of the Effects Diclofenac has on Japanese Medaka (Oryzias latipes) using Real-time PCR.” Chemosphere 67 (11): 2115–2121.
   PubMed Web of Science ®Google Scholar
• Hoque, E. 2003. Verfahren zum Abbau von Xenobiotika durch Pilzarten mit Monooxygenase-/Dioxygenase-Aktivität in Gegenwart von Pilzen mit Glutathion-S-Transferase-Aktivität. German Patent DE, 101 (25): 365, filed May 23.
   Google Scholar
• Hoque, E., S. Pflugmacher, J. Fritscher, and M. Wolf. 2007. “Induction of Glutathione S-transferase in Biofilms and Germinating Spores of Mucor hiemalis Strain EH5 from Cold Sulfidic Spring Waters.” Applied and Environmental Microbiology 73 (8): 2697–2707.
   PubMed Web of Science ®Google Scholar
• Huber, C. 2011. “Evaluation of the Detoxification Capacity for the Human Pharmaceuticals Paracetamol and Diclofenac in Plants for Phytoremediation.” PhD thesis, Technische Universität München.
   Google Scholar
• Jones, O. A. H., N. Voulvoulis, and J. N. Lester. 2007. “The Occurrence and Removal of Selected Pharmaceutical Compounds in a Sewage Treatment Works Utilising Activated Sludge Treatment.” Environmental Pollution 145 (3): 738–744.
   PubMed Web of Science ®Google Scholar
• Kasprzyk-Hordern, B., R. M. Dinsdale, and A. J. Guwy. 2009. “The Removal of Pharmaceuticals, Personal Care Products, Endocrine Disruptors and Illicit Drugs during Wastewater Treatment and its Impact on the Quality of Receiving Waters.” Water Research 43 (2): 363–380.
   PubMed Web of Science ®Google Scholar
• Kotyza, J., P. Soudek, Z. Kafka, and T. Vanĕk. 2010. “Phytoremediation of Pharmaceuticals-Preliminary Study.” International Journal of Phytoremediation 12 (3): 306–16.
   PubMed Web of Science ®Google Scholar
• Marco-Urrea, E., M. Pérez-Trujillo, C. Cruz-Morató, G. Caminal, and T. Vicent. 2010. “Degradation of the Drug Sodium Diclofenac by Trametes versicolor Pellets and Identification of Some Intermediates by NMR.” Journal of Hazardous Materials 176 (1): 836–842.
   PubMed Web of Science ®Google Scholar
• Nepejchalova, L., Z. Svobodova, J. Kolářová, K. Frgalova, J. Valova, and D. Némethová. 2008. “Oxytetracycline Assay in Pond Sediment.” Acta Veterinaria Brunensis 77 (3): 461–466.
   Web of Science ®Google Scholar
• Oaks, J. L., M. Gilbert, M. Z. Virani, R. T. Watson, C. U. Meteyer, B. A. Rideout, H. L. Shivaprasad, S. Ahmed, M. J. I. Chaudhry, M. Arshad, S. Mahmood, and A. A. Ali Khan. 2004. “Diclofenac Residues as the Cause of Vulture Population Decline in Pakistan.” Nature 427 (6975): 630–633.
   PubMed Web of Science ®Google Scholar
• Osorio-Lozada, A., S. Surapaneni, G. L. Skiles, and R. Subramanian. 2008. “Biosynthesis of Drug Metabolites using Microbes in Hollow Fiber Cartridge Reactors: Case Study of Diclofenac Metabolism by Actinoplanes Species.” Drug and Metabolism Disposition 36: 234–240.
   PubMed Web of Science ®Google Scholar
• Paxéus, N. 2004. “Removal of Selected Non-steroidal Anti-inflammatory Drugs (NSAIDs), Gemfibrozil, Carbamazepine, Beta-blockers, Trimethoprim and Triclosan in Conventional Wastewater Treatment Plants in Five EU Countries and their Discharge to the Aquatic Environment.” Water Science and Technology 50 (5): 253–60.
   PubMed Web of Science ®Google Scholar
• Pérez-Estrada, L. A., S. Malato, W. Gernjak, A. Agüera, E. M. Thurman, I. Ferrer, and A. R. Fernández-Alba. 2005. “Photo-fenton Degradation of Diclofenac: Identification of Main Intermediates and Degradation Pathway.” Environmental Science and Technology 39 (21): 8300–6.
   PubMed Web of Science ®Google Scholar
• Poiger, T., H-R. Buser, and M. D. ller. 2001. “Photodegradation of the Pharmaceutical Drug Diclofenac in a Lake: Pathway, Field Measurements, and Mathematical Modeling.“ Environmental Toxicology and Chemistry 20: 256–263.
   PubMed Web of Science ®Google Scholar
• Reif, R., S. Suárez, F. Omil, and J. M. Lema. 2008. “Fate of Pharmaceuticals and Cosmetic Ingredients During the Operation of a MBR Treating Sewage.” Desalination 221: 511–517.
   Web of Science ®Google Scholar
• Rodarte-Morales, A. I., G. Feijoo, M. T. Moreira, and J. M. Lema. 2012. “Biotransformation of Three Pharmaceutical Active Compounds by the Fungus Phanerochaete chrysosporium in a Fed Batch Stirred Reactor under Air and Oxygen Supply.” Biodegradation 23: 145–156.
   PubMed Web of Science ®Google Scholar
• Schwaiger, J., H. Ferling, U. Mallow, H. Wintermayr, and R. D. Negele. 2004. “Toxic Effects of the Non-steroidal Anti-inflammatory Drug Diclofenac: Part I: Histopathological Alterations and Bioaccumulation in Rainbow Trout.” Aquatic Toxicology 68 (2): 141–150.
   PubMed Web of Science ®Google Scholar
• Shen, S. J., M. R. Marchick, M. R. Davis, G. A. Doss, and L. R. Pohl. 1999. “Metabolic Activation of Diclofenac by Human Cytochrome P450 3A4: Role of 5-Hydroxydiclofenac.” Chemical Research in Toxicology 12: 214–222.
   PubMed Web of Science ®Google Scholar
• Suárez, S., M. Ramil, F. Omil, and J. M. Lema. 2005. “Removal of Pharmaceutically Active Compounds in Nitrifying-denitrifying Plants.” Water Science and Technology 52 (8): 9–14.
   PubMed Web of Science ®Google Scholar
• Tang, W., R. A. Stearns, G. Y. Kwei, S. A. Iliff, R. R. Miller, M. A. Egan, N. X. Yu, D. C. Dean, S. Kumar, M. Shou, J. H. Lin, and T. A. Baillie. 1999a. “Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism.” Journal of Pharmacology and Experimental Therapeutics 291 (3): 1068–74.
   PubMed Web of Science ®Google Scholar
• Tang W., R. A. Stearns, S. M. Bandiera, Y. Zhang, C. Raab, M. P. Braun, D. C. Dean, J. Pang, K. H. Leung, G. A. Doss, J. R. Strauss, G. Y. Kwei, T. H. Rushmore, S. L. Chiu, and T. A. Baillie. 1999b. “Studies on Cytochrome P-450-Mediated Bioactivation of Diclofenac in Rats and in Human Hepatocytes: Identification of Glutathione Conjugated Metabolites.” Drug Metabolism and Disposition 27 (3): 365–372.
   PubMed Web of Science ®Google Scholar
• Ternes, T. A. 1998. “Occurrence of Drugs in German Sewage Treatment Plants and Rivers.” Water Research 32 (11): 3245–3260.
   Web of Science ®Google Scholar
• Ternes, T. A. 2001. “Analytical Methods for the Determination of Pharmaceuticals in Aqueous Environmental Samples.” TrAC Trends in Analytical Chemistry 20 (8): 419–434.
   Web of Science ®Google Scholar
• Thomas, K. V., and M. J. Hilton. 2004. “The Occurrence of Selected Human Pharmaceutical Compounds in UK Estuaries.” Marine Pollution Bulletin 49 (5–6): 436–44.
   PubMed Web of Science ®Google Scholar
• Tixier, C., H. P. Singer, S. Oellers, and S. R. Müller. 2003. “Occurrence and Fate of Carbamazepine, Clofibric Acid, Diclofenac, Ibuprofen, Ketoprofen, and Naproxen in Surface Waters.” Environmental Science and Technology 37 (6): 1061–1068.
   PubMed Web of Science ®Google Scholar
• Verlicchi, P., M. Al Aukidy, and E. Zambello. 2012. “Occurrence of Pharmaceutical Compounds in Urban Wastewater: Removal, Mass Load and Environmental Risk After a Secondary Treatment-A Review.” Science of the Total Environment 429: 123–55.
   PubMed Web of Science ®Google Scholar
• Walker, C. H., R. M. Sibly, S. P. Hopkin, and D. B. Peakall. 2001. Principles of Ecotoxicology, 2nd edn. London: Taylor & Francis.
   Google Scholar
• Webb, S. F. 2001. “A Data Based Perspective on the Environmental Risk Assessment of Human Pharmaceuticals II – Aquatic Risk Characterization.” In Pharmaceuticals in the Environment, edited by D. R. Dietrich, S. F. Webb, and T. Petry, 203–219. Berlin: Heidelberg.
   Google Scholar
• Zhang, Y., S. U. Geißen, and C. Gal. 2008. “Carbamazepine and Diclofenac: Removal in Wastewater Treatment Plants and Occurrence in Water Bodies.” Chemosphere 73 (8): 1151–1161.
   PubMed Web of Science ®Google Scholar
• Zhang, D. Q., T. Hua, R. M. Gersberg, J. Zhu, W. J. Ng, and S. K. Tan. 2012. “Fate of Diclofenac in Wetland Mesocosms Planted with Scirpus validus.” Ecological Engineering 49: 59–64.
   Web of Science ®Google Scholar